Jacques De Keyser

19.9k total citations · 1 hit paper
329 papers, 12.8k citations indexed

About

Jacques De Keyser is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Jacques De Keyser has authored 329 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Pathology and Forensic Medicine, 91 papers in Neurology and 77 papers in Epidemiology. Recurrent topics in Jacques De Keyser's work include Multiple Sclerosis Research Studies (104 papers), Acute Ischemic Stroke Management (60 papers) and Neuroscience and Neuropharmacology Research (31 papers). Jacques De Keyser is often cited by papers focused on Multiple Sclerosis Research Studies (104 papers), Acute Ischemic Stroke Management (60 papers) and Neuroscience and Neuropharmacology Research (31 papers). Jacques De Keyser collaborates with scholars based in Netherlands, Belgium and United States. Jacques De Keyser's co-authors include Geert Sulter, Marcus Koch, Nadine Wilczak, Maarten Uyttenboogaart, Jop Mostert, Georges Vauquelin, Guy Ebinger, Patrick C. Vroomen, Guy Nagels and Marie D’hooghe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Jacques De Keyser

324 papers receiving 12.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of the Barthel Index and Modified Rankin Scale in Acute Stroke Trials

1999 883 citations Geert Sulter, Jacques De Keyser et al. profile →

Peers

Countries citing papers authored by Jacques De Keyser

Since Specialization

Citations

This map shows the geographic impact of Jacques De Keyser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques De Keyser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques De Keyser more than expected).

Fields of papers citing papers by Jacques De Keyser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques De Keyser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques De Keyser. The network helps show where Jacques De Keyser may publish in the future.

Co-authorship network of co-authors of Jacques De Keyser

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques De Keyser. A scholar is included among the top collaborators of Jacques De Keyser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques De Keyser. Jacques De Keyser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes 2020 ·Annals of Clinical and Translational Neurology ·(unknown), (unknown), Mireia Valles‐Colomer, Ann Van Remoortel, Marie Joossens, Jacques De Keyser, Guy Nagels, Marie D’hooghe, Jeroen Raes	81
2	Post-stroke infections associated with spleen volume reduction: A pilot study 2020 ·PLoS ONE ·(unknown), Ilse Peeters, Koenraad Nieboer, Anne‐Marie Vanbinst, Jacques De Keyser, Sylvie De Raedt	14
3	Feasibility, Reliability and Predictive Value Of In-Ambulance Heart Rate Variability Registration 2016 ·PLoS ONE ·Laetitia Yperzeele, Robbert‐Jan Van Hooff, Ann De Smedt, Guy Nagels, Ives Hubloue, Jacques De Keyser, Raf Brouns	12
4	Cerebral blood flow velocity changes during upright positioning in bed after acute stroke: an observational study 2013 ·BMJ Open ·Marcel Aries, Jan Willem J. Elting, Roy E. Stewart, Jacques De Keyser, Berry Kremer, Patrick C. Vroomen	25
5	Relative contribution of cognitive and physical disability components to quality of life in MS 2013 ·Journal of the Neurological Sciences ·Jeroen Van Schependom, Marie D’hooghe, (unknown), (unknown), Mieke D’hooge, Marie-Claire Haelewyck, Jacques De Keyser, Guy Nagels	8
6	Acute Stroke Management in Patients Taking Dabigatran 2012 ·CNS Neuroscience & Therapeutics ·Raf Brouns, Robbert‐Jan Van Hooff, Ann De Smedt, Maarten Moens, Sylvie De Raedt, Maarten Uyttenboogaart, Gert‐Jan Luijckx, Kristin Jochmans, Jacques De Keyser	5
7	Prediction of hospitalization duration for acute stroke in Belgium 2012 ·Acta Neurologica Belgica ·(unknown), Ann De Smedt, Robbert‐Jan Van Hooff, Sylvie De Raedt, (unknown), Koen Putman, Jacques De Keyser, Raf Brouns	7
8	Progesterone and dexamethasone differentially regulate the IGF-system in glial cells 2009 ·Neuroscience Letters ·Daniel Chesik, Jacques De Keyser	38
9	The Insulin‐like Growth Factor System in Multiple Sclerosis 2007 ·International review of neurobiology ·Daniel Chesik, Nadine Wilczak, Jacques De Keyser	45
10	Casemanagement voor mensen met een chronische ziekte: Kenmerken van een vraaggericht casemanagement model in een multidisciplinaire en transmurale setting 2006 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Klaske Wynia, (unknown), (unknown), Jacques De Keyser	1
11	Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis 2005 ·Acta Neurologica Scandinavica ·Rachael L. Bosma, Klaske Wynia, Eva Havlíková, Jacques De Keyser, Berrie Middel	57
12	N-acetylaspartate: Serum marker of reperfusion in ischemic stroke 2004 ·Journal of Stroke and Cerebrovascular Diseases ·(unknown), Geert Sulter, (unknown), Gert-Jan Luijckx, Albert Teelken, Jacques De Keyser	7
13	Are Astrocytes Central Players in the Pathophysiology of Multiple Sclerosis? 2003 ·Archives of Neurology ·Jacques De Keyser, Esther Zeinstra, Elliot M. Frohman	71
14	Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis 1998 ·Neuroscience Letters ·Nadine Wilczak, (unknown), Remco Bredewold, (unknown), Albert Teelken, Jacques De Keyser	23
15	Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in the Treatment of Acute Ischaemic Stroke 1994 ·Cerebrovascular Diseases ·Nils Wahlgren, Douglas G MacMahon, Jacques De Keyser, Bent Indredavik, Torsten Ryman	199
16	Insulin-like growth factor-I receptor densities in human frontal cortex and white matter during aging, in Alzheimer's disease, and in Huntington's disease 1994 ·Neuroscience Letters ·Jacques De Keyser, Nadine Wilczak, Anita Goossens	36
17	Subtypes and localization of dopamine receptors in human brain 1993 ·Neurochemistry International ·Jacques De Keyser	30
18	What intracranial tissues in humans contain sumatriptan-sensitive serotonin 5-HT1-type receptors? 1993 ·Neuroscience Letters ·Jacques De Keyser, Georges Vauquelin, J.-P. De Backer, (unknown), Nadine Wilczak	12
19	Disappearance of Akathisia Following Electroconvulsive Treatment 1986 ·Clinical Neuropharmacology ·Jacques De Keyser, Hugo D’Haenen	2
20	Television induced seizures in alcoholics. 1984 ·BMJ ·Jacques De Keyser, Alex Michotte, Guy Ebinger	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact